Key Insights

Highlights

Treatment Research

2 treatments under study, led by Medical Treatment Alone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05899582Not ApplicableRecruitingPrimary

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

Showing all 1 trials

Research Network

Common Treatments

  • Medical Treatment Alone1
  • Extracranialintracranial Bypass Surgery1

Active Sponsors

  • Xuanwu Hospital, Beijing1

Top Investigators

Related Conditions

  • Infarction Middle Cerebral Artery1

Activity Timeline